147
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Successful Pregnancy Following Preimplantation Genetic Diagnosis of Adrenoleukodystrophy by Detection of Mutation on the ABCD1 Gene

ORCID Icon, , , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 313-319 | Published online: 14 Jul 2021

References

  • Wiesinger C, Eichler FS, Berger J. The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet. 2015;8:109–121. doi:10.2147/TACG.S49590
  • Kemp S, Pujol A, Waterham HR, et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 2001;18(6):499–515. doi:10.1002/humu.1227
  • Lee S, Clinard K, Young SP, et al. Evaluation of X-linked adrenoleukodystrophy newborn screening in North Carolina. JAMA Netw Open. 2020;3(1):e1920356. doi:10.1001/jamanetworkopen.2019.20356
  • Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361(6414):726–730. doi:10.1038/361726a0
  • Migeon BR, Moser HW, Moser AB, Axelman J, Sillence D, Norum RA. Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci U S A. 1981;78(8):5066–5070. doi:10.1073/pnas.78.8.5066
  • van Roermund CWT, Visser WF, Ijlst L, et al. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 2008;22(12):4201–4208. doi:10.1096/fj.08-110866
  • Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem. 2013;288(26):19269–19279. doi:10.1074/jbc.M112.445445
  • Kawaguchi K, Mukai E, Watanabe S, et al. Acyl-CoA thioesterase activity of peroxisomal ABC protein ABCD1 is required for the transport of very long-chain acyl-CoA into peroxisomes. Sci Rep. 2021;11(1):2192. doi:10.1038/s41598-021-81949-3
  • Galea E, Launay N, Portero-Otin M, et al. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta. 2012;1822(9):1475–1488. doi:10.1016/j.bbadis.2012.02.005
  • Raymond GV, Seidman R, Monteith TS, et al. Head trauma can initiate the onset of adreno-leukodystrophy. J Neurol Sci. 2010;290(1–2):70–74. doi:10.1016/j.jns.2009.11.005
  • Engelen M, Kemp S, De visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7:51. doi:10.1186/1750-1172-7-51
  • Zhu J, Eichler F, Biffi A, Duncan CN, Williams DA, Majzoub JA. The changing face of adrenoleukodystrophy. Endocr Rev. 2020;41(4):577–593. doi:10.1210/endrev/bnaa013
  • Turk BR, Theda C, Fatemi A, Moser AB. X‐linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020;80(1):52–72. doi:10.1002/jdn.10003
  • Mallack EJ, Turk BR, Yan H, et al. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines. J Inherit Metab Dis. 2021;44(3):728–739. doi:10.1002/jimd.12356
  • Regelmann MO, Kamboj MK, Miller BS, et al. Adrenoleukodystrophy: guidance for adrenal surveillance in males identified by newborn screen. J Clin Endocrinol Metab. 2018;103(11):4324–4331. doi:10.1210/jc.2018-00920
  • Bezman L, Moser AB, Raymond GV, et al. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol. 2001;49(4):512–517. doi:10.1002/ana.101
  • Wang Y, Busin R, Reeves C, et al. X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism. Mol Genet Metab. 2011;104(1–2):160–166. doi:10.1016/j.ymgme.2011.05.016
  • Raymond GV, Moser AB, Fatemi A, et al. X-linked adrenoleukodystrophy. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews®. Seattle: University of Washington; 1993.
  • Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature. 1990;344(6268):768–770. doi:10.1038/344768a0
  • Imudia AN, Plosker S. The past, present, and future of preimplantation genetic testing. Clin Lab Med. 2016;36(2):385–399. doi:10.1016/j.cll.2016.01.012. PMID: 27235919.
  • Harper JC, Boelaert K, Geraedts J, et al. ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. Hum Reprod Oxf Engl. 2006;21(1):3–21. doi:10.1093/humrep/dei292
  • Cheung VG, Nelson SF. Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA. Proc Natl Acad Sci U S A. 1996;93(25):14676–14679. doi:10.1073/pnas.93.25.14676
  • Czyz ZT, Kirsch S, Polzer B. Principles of whole-genome amplification. Methods Mol Biol Clifton NJ. 2015;1347:1–14. doi:10.1007/978-1-4939-2990-0_1
  • Engelen M, Barbier M, Dijkstra IM, et al. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain. 2014;137(Pt 3):693–706. doi:10.1093/brain/awt361. PMID: 24480483.
  • Semmler A, Köhler W, Jung HH, Weller M, Linnebank M. Therapy of X-linked adrenoleukodystrophy. Expert Rev Neurother. 2008;8(9):1367–1379. doi:10.1586/14737175.8.9.1367
  • Moser HW, Moser AB, Powers JM, et al. The prenatal diagnosis of adrenoleukodystrophy. Demonstration of increased hexacosanoic acid levels in cultured amniocytes and fetal adrenal gland. Pediatr Res. 1982;16(3):172–175. doi:10.1203/00006450-198203000-00002
  • Ke L, Wang Z, Huang H, et al. [Prenatal molecular diagnosis of four fetuses at high risk for X-linked adrenoleukodystrophy]. Zhonghua Fu Chan Ke Za Zhi. 2008;43(1):25–28. Chinese.
  • Imamura A, Suzuki Y, Song XQ, et al. Prenatal diagnosis of adrenoleukodystrophy by means of mutation analysis. Prenat Diagn. 1996;16(3):259–261. doi:10.1002/(SICI)1097-0223(199603)16:3<259::AID-PD840>3.0.CO;2-E
  • Gigarel N, Frydman N, Burlet P, et al. Single cell co-amplification of polymorphic markers for the indirect preimplantation genetic diagnosis of hemophilia A, X-linked adrenoleukodystrophy, X-linked hydrocephalus and incontinentia pigmenti loci on Xq28. Hum Genet. 2004;114(3):298–305. doi:10.1007/s00439-003-1063-9
  • Lledó B, Bernabeu R, Ten J, Galán FM, Cioffi L. Preimplantation genetic diagnosis of X-linked adrenoleukodystrophy with gender determination using multiple displacement amplification. Fertil Steril. 2007;88(5):1327–1333. doi:10.1016/j.fertnstert.2007.01.034
  • Iglesias M, Ceballos P, Giménez C, García-Nebreda MI, Domínguez R, García-Enguídanos A. Pregnancy outcome after preimplantation genetic diagnosis in an affected couple with X-linked adrenoleukodystrophy. Fertil Steril. 2008;90(5):2010.e1–3. doi:10.1016/j.fertnstert.2008.02.011
  • Borgulova I, Putzova M, Soldatova I, et al. Preimplantation genetic diagnosis of X-linked diseases examined by indirect linkage analysis. Bratisl Lek Listy. 2015;116(9):542–546. doi:10.4149/bll_2015_103. PMID: 26435019.
  • Sermon K. Current concepts in preimplantation genetic diagnosis (PGD): a molecular biologist’s view. Hum Reprod Update. 2002;8(1):11–20. doi:10.1093/humupd/8.1.11
  • Harper JC, Wilton L, Traeger-Synodinos J, et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update. 2012;18(3):234–247. doi:10.1093/humupd/dmr052
  • Basille C, Frydman R, El Aly A, et al. Preimplantation genetic diagnosis: state of the art. Eur J Obstet Gynecol Reprod Biol. 2009;145(1):9–13. doi:10.1016/j.ejogrb.2009.04.004
  • Sciorio R, Tramontano L, Catt J. Preimplantation genetic diagnosis (PGD) and genetic testing for aneuploidy (PGT-A): status and future challenges. Gynecol Endocrinol. 2020;36(1):6–11. doi:10.1080/09513590.2019.1641194
  • Capalbo A, Bono S, Spizzichino L, et al. Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast: insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development. Hum Reprod Oxf Engl. 2013;28(2):509–518. doi:10.1093/humrep/des394
  • Haapaniemi Kouru K, Malmgren H, Nordenskjöld M, Fridström M, Csemiczky G, Blennow E. One-cell biopsy significantly improves the outcome of preimplantation genetic diagnosis (PGD) treatment: retrospective analysis of 569 PGD cycles at the Stockholm PGD centre. Hum Reprod Oxf Engl. 2012;27(9):2843–2849. doi:10.1093/humrep/des235
  • Slatko BE, Gardner AF, Ausubel FM. Overview of next-generation sequencing technologies. Curr Protoc Mol Biol. 2018;122(1):e59. doi:10.1002/cpmb.59
  • Li G, Niu W, Jin H, et al. Importance of embryo aneuploidy screening in preimplantation genetic diagnosis for monogenic diseases using the karyomap gene chip. Sci Rep. 2018;8(1):3139. doi:10.1038/s41598-018-21094-6
  • Forman EJ, Hong KH, Franasiak JM, Scott RT. Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates. Am J Obstet Gynecol. 2014;210(2):157.e1–6. doi:10.1016/j.ajog.2013.10.016
  • Giménez C, Sarasa J, Arjona C, et al. Karyomapping allows preimplantation genetic diagnosis of a de-novo deletion undetectable using conventional PGD technology. Reprod Biomed Online. 2015;31(6):770–775. doi:10.1016/j.rbmo.2015.08.017
  • Goldman KN, Nazem T, Berkeley A, Palter S, Grifo JA. Preimplantation Genetic Diagnosis (PGD) for monogenic disorders: the value of concurrent aneuploidy screening. J Genet Couns. 2016;25(6):1327–1337. doi:10.1007/s10897-016-9975-4